Name | r(+)-bay k 8644 |
---|---|
Synonyms |
Methyl 2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydro-3-pyridinecarboxylate
(±)-Bay K8644 Bay K 8644 Methyl (4R)-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydro-3-pyridinecarboxylate Bay K 8644,(±)- methyl 2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate (±)-Bay K 8644 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-, methyl ester Methyl (4R)-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate (R)-Bay-K-8644 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-, methyl ester, (4R)- Bay K8644 Bay-K-8644 ((R)-(+)-) |
Description | Bay-K-8644 (R)-(+)- is a calcium channel inhibitor. Bay-K-8644 (R)-(+)- inhibits Ba2+ currents (IBa) (IC50=975 nM). |
---|---|
Related Catalog | |
Target |
IC50: 975 nM (IBa)[1] |
In Vitro | (±)-Bay K 8644, a conventional racemic mixture of Bay K 8644, is widely used as an L-type Ca2+ channel agonist. Each optical isomer possesses opposite effects on IBa, Bay-K-8644 (R)-(+)- as an antagonist and S(-)-Bay K 8644 as an agonist. Bay-K-8644 (R)-(+)- inhibits Ba2+ currents (IBa) (IC50=975 nM). When Bay-K-8644 (R)-(+)- (0.5 μM) is applied, IBa is suppressed to 71±10% of control. In the presence of Bay-K-8644 (R)-(+)- (0.5 μM), additional application of forskolin and sodium nitroprusside (SNP) further inhibits IBa[1]. Bay-K-8644 (R)-(+)- is a calcium channel inhibitor[2]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 429.2±45.0 °C at 760 mmHg |
Molecular Formula | C16H15F3N2O4 |
Molecular Weight | 356.297 |
Flash Point | 213.4±28.7 °C |
Exact Mass | 356.098389 |
PSA | 84.15000 |
LogP | 2.39 |
Vapour Pressure | 0.0±1.0 mmHg at 25°C |
Index of Refraction | 1.543 |